Specimens: | 1 ml Citrated plasma, frozen (cp) |
Preanalytics/Notes: | Please always send a separate specimen for this test. |
Method: | Chromogenic assay |
Dimension: | ng/ml |
Set-up: | Mon Tue Wed Thu Fri Sat Sun |
Duration: | 10 days |
Indication/Significance: | Monitoring therapy with rivaroxaban. Detection of residual levels or overdoses. |
Interpretation: |
Rivaroxaban is an orally more… Rivaroxaban is an orally ingested, direct inhibitor of factor Xa. It is used to anticoagulate patients suffering from atrial fibrillation or thromboembolic disease. |
both sex | ||
---|---|---|
For prevention after coronary events, 2,5 mg are taken twice daily. The following plasma levels were measured (geometric mean and 90% interval): Trough level: 9,2 ng/ml [4,4-18 ng/ml] Peak level: 47 ng/ml [13-123 ng/ml] For treatment of deep vein thrombosis and pulmonary embolism, 20 mg are taken once daily. The following peak levels were measured (geometric mean and 90% interval): Trough level: 32 ng/ml [6-239 ng/ml] Peak level: 215 ng/ml [22-535 ng/ml] Source: Manufacturer's official statement, january 2021. |
Die Kosten werden für den i. d. R. genutzten 1,15-fachen GOÄ-Satz dargestellt. Wird die Untersuchung nicht in Ihrem regionalen Labor durchgeführt, erfolgt die Analyse in dem Labor, das im Leistungsverzeichnis genannt ist. In diesem Fall gilt der dort für die Untersuchung angegebene Preis.